ֲý

Skip to Content on ֲý.org
You're location is
All Regions
ֲýr

Nationally Recognized Pediatric Care

Our hospitals are ranked by U.S. News & World Report as among the best in the nation in multi-specialties.

Find Out Why!
Closeup of a person holding a phone using the ֲý app.

We Make Health Care Easy With the ֲý App

Access communications, appointment and symptom tracking and more.

Online Bill Pay

Paying a bill online is easy and secure.

Learn More

Send a Free E-Card

Brighten the day of your loved one staying at one of our hospitals. 

Give It a Try
Young child posing with arms out like he is flying.

KidsHealth Library

Healthy living for parents, kids and teens.

Meet Our Team

Learn more about our physician researchers, clinicians and scientists.

Find a Researcher
# #

    Corinna L. Schultz, MD

    Hematology/Oncology
    (800) 416-4441
    Researcher Profile

    Primary Office

    ֲý Children's Hospital, Delaware ֲý Children's Hospital, Delaware 1600 Rockland Road Wilmington, DE 19803
    Appointment: (800) 416-4441

    Other Offices

    Get to Know Me

    Dr. Corinna L. Schultz is a pediatric hematologist/oncologist and an assistant professor at Sidney Kimmel Medical College. She's an invited lecturer, presenter, published medical journal author, active researcher, and member of multiple medical societies, serving on a national committee of the Children's Oncology Group.

    Why I Treat Children

    Even before medical school, I knew I wanted to work with children. Then I did my pediatric rotation and that sealed it! I love being around children and teens. They make everything better. It is amazing how a child who is dealing with an illness still finds a way to smile. I see the way kids don't let anything stop them, even cancer. It's inspiring. The reason I chose hematology and oncology is that they combine everything I love about medicine and find the most interesting. For me, it's the perfect blend of primary care, critical care, and specialty medicine. I love that it's multidisciplinary and that the field is progressing so quickly — with developments in new medications for sickle cell disease and hemophilia and new disease cures like gene therapy coming soon. It's an exciting time to be a hematology and oncology specialist.

    What I'm Passionate About

    I'm passionate about taking care of kids, educating and communicating with children, families and medical professionals about hematology, and advancing health and health care through health services research to improve the way that we (within medicine, in general, and our hospital, in particular) deliver hematology and oncology care. My medical interests include: Sickle cell disease Sickle cell trait Other hemoglobin traits Bleeding disorders such as Hemophilia and von Willebrand disease Clotting disorders Iron deficiency anemia Patient portals Patient-physician communication  

    How I Try to Make A Difference

    I try to make a difference in every care setting I find myself in. I try to be exceptionally present for my patients and their families, and make sure they get their questions answered. I worked with the adult hematologists at Wilmington Hospital to create the first federally funded Hemophilia Treatment Center to care for children in Delaware with bleeding and clotting disorders. I also enjoy being active within the hospital, serving on specific groups and committees such as the Ethics Committee, Pharmacy and Therapeutics Committee, and Pediatric Clinical Competency Committee. I feel it's important to be active within the hospital and the field to ensure we're providing the highest quality and safest care possible. I also work to make a difference by doing research within my specialty and in healthcare delivery.

    Education & Training

    Fellowship

    • Pediatric Hematology/Oncology - Children's Hospital of Philadelphia, 2014

    Residency

    • Pediatrics - Hasbro Children's Hospital, 2011

    Medical/Dental School

    • M.D. - Thomas Jefferson University - Medical College, 2007
    • MSHP - University of Pennsylvania, 2014

    Board Certifications

    • American Board of Pediatrics/General Pediatrics
    • American Board of Pediatrics/Pediatric Hematology-Oncology

    Awards & Recognition

    • 2013 ASH Abstract Achievement Award for an abstract on practice patterns in the management of newly diagnosed childhood immune thrombocytopenic purpura (ITP)
    • 2007 Edward J. Moore Memorial Prize in Pediatrics, Jefferson Medical College, Honorable Mention for “the student demonstrating the greatest aptitude in pediatrics”
    • 2018 Faculty Educator of the Month, June 2018, ֲý/A.I. duPont Hospital for Children, Sidney Kimmel Medical College
    • 2019 Dean’s Award for Excellence in Education, Sidney Kimmel Medical College.
    • 2019 Faculty Educator of the Month, July 2019, ֲý/A.I. duPont Hospital for Children, Sidney Kimmel Medical College

    • Anemia
    • Blood Disorders
    • Cancer Care
    • Hemophilia
    • Immune Thrombocytopenia
    • Neutropenia
    • Platelet Abnormalities
    • Retinoblastoma
    • Sickle Cell Disease

    Research Activities

    • How to improve the documentation and disclosure of sickle cell trait across the lifespan
    • Use of hydroxyurea in sickle cell disease
    • Patient portal use by parents of children with chronic illness (a patient portal is a secure online website that gives patients and families convenient 24-hour access to their personal health information)
    • Sickle cell disease and its effects

    • Apixaban versus no anticoagulation for the prevention of venous thromboembolism in children with newly diagnosed acute lymphoblastic leukaemia or lymphoma (PREVAPIX-ALL): a phase 3, open-label, randomised, controlled trial; The Lancet Haematology; (2024).

    • Social Determinants of Health in Cardio-Oncology; JACC: CardioOncology; (2024).

    • Cerebral revascularization surgery reduces cerebrovascular events in children with sickle cell disease and moyamoya syndrome: Results of the stroke in sickle cell revascularization surgery retrospective study; Pediatric Blood & Cancer; (2023).

    • Persistent Disparities in Pediatric Health Care Engagement During the COVID-19 Pandemic; Public Health Reports; (2023).

    • Family‐centered communication in pediatric sickle cell disease; Pediatric Blood & Cancer; (2022).

    • COVID-19 Exposure and Family Impact Scales for Adolescents and Young Adults; Journal of Pediatric Psychology; (2022).

    • Online patient portal use by caregivers in pediatric oncology: Are we widening sociodemographic disparities?; Pediatric Blood & Cancer; (2021).

    • Reproductive intentions in mothers of young children with sickle cell disease; Pediatric Blood & Cancer; (2020).

    • Use of plasma‐derived factor X concentrate in neonates and infants with congenital factor X deficiency; Journal of Thrombosis and Haemostasis; (2020).

    • Hereditary elliptocytosis‐associated alpha‐spectrin mutation p.L155dup as a modifier of sickle cell disease severity; Pediatric Blood & Cancer; (2019).

    • Are on‐line patient portals meeting test result preferences of caregivers of children with cancer? A qualitative exploration; Pediatric Blood & Cancer; (2018).

    • The Influence of Adolescence on Parents' Perspectives of Testing and Discussing Inherited Cancer Predisposition; Journal of Genetic Counseling; (2018).

    • Coexisting Juvenile Dermatomyositis and Sickle Cell Disease: Maintaining a High Degree of Suspicion; The Journal of Pediatrics; (2017).

    • Adherence to prompt fever evaluation in children with sickle cell disease and the health belief model; Pediatric Blood & Cancer; (2015).

    • Influence of the American Society of Hematology Guidelines on the Management of Newly Diagnosed Childhood Immune Thrombocytopenia; JAMA Pediatrics; (2014).

    • Tryptophan Substitution of a Putative D4S6 Gating Hinge Alters Slow Inactivation in Cardiac Sodium Channels; Biophysical Journal; (2005).

    • State-dependent block of voltage-gated Na+ channels by amitriptyline via the local anesthetic receptor and its implication for neuropathic pain; Pain; (2004).

    • Mexiletine block of wild-type and inactivation-deficient human skeletal muscle hNav1.4 Na+channels; The Journal of Physiology; (2004).

    • State-dependent Block of Wild-type and Inactivation-deficient Na+Channels by Flecainide; The Journal of General Physiology; (2003).

    • Tryptophan Scanning of D1S6 and D4S6 C-Termini in Voltage-Gated Sodium Channels; Biophysical Journal; (2003).

    • English